Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 PK of Aerosolized Amikacin/Fosfomycin in Healthy Volunteers
NCT02709265Phase 1Completed
- Sponsor
- Cardeas Pharma Corp.
- Start
- Apr 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of amikacin and fosfomycin in ventilator-associated pneumonia (VAP) (5 cohorts), sponsored by Cardeas Pharma Corp. Primary endpoint: Peak plasma concentration. Started Apr 2016; status: completed.
02
Drugs
amikacinfosfomycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02709265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709265.